New China Approvals Include Amgen, Sanofi, Hengrui Drugs, Innovent Biosimilar

 
• By Brian Yang
  
Beijing, China (ESB Professional/Shutterstock.com)
CHINA CONTINUES NEW APPROVALS RUSH POST-CORONAVIRUS • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia